GSK-208136/018 (MeMuRu-OKA-018)

Study to evaluate immunogenicity and safety of GSK Biologicals’ MeMuRu-OKA vaccine compared to concomitant administrations of GSK Biologicals’ Priorix™ and Varilrix™ vaccines
Combined Measles, Mumps, Rubella, Varicella Vaccine
208136/018 (MeMuRu-OKA-018)
Measles; Mumps; Rubella; Varicella
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
September 2015